Recombinant human CD28 protein (Active) is a Human Fragment protein, in the 19 to 152 aa range, expressed in HEK 293, with >=95% purity, < 0.2 EU/µg endotoxin level and suitable for SDS-PAGE, FuncS.
>=95% SDS-PAGE
< 0.2 EU/µg
HEK 293 cells
Fc tag C-Terminus
SDS-PAGE, FuncS
Yes
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application FuncS | Reactivity Reacts | Dilution info - | Notes - |
Involved in T-cell activation, the induction of cell proliferation and cytokine production and promotion of T-cell survival. Enhances the production of IL4 and IL10 in T-cells in conjunction with TCR/CD3 ligation and CD40L costimulation (PubMed:8617933). Isoform 3 enhances CD40L-mediated activation of NF-kappa-B and kinases MAPK8 and PAK2 in T-cells (PubMed:15067037).
T-cell-specific surface glycoprotein CD28, TP44, CD28
Recombinant human CD28 protein (Active) is a Human Fragment protein, in the 19 to 152 aa range, expressed in HEK 293, with >=95% purity, < 0.2 EU/µg endotoxin level and suitable for SDS-PAGE, FuncS.
T-cell-specific surface glycoprotein CD28, TP44, CD28
>=95% SDS-PAGE
< 0.2 EU/µg
HEK 293 cells
Fc tag C-Terminus
SDS-PAGE, FuncS
Yes
Human biotinylated CD80, Fc Tag can bind to immobilized human CD28, Fc Tag at 1 μg/mL, 100 μL/well with a linear range of 0.03 – 0.81 μg/mL.
No
Human
Reconstitute in sterile PBS, pH 7.4 to a concentration of 10 µg/ml
pH: 7.4
Constituents: 95% PBS, 5% Trehalose
Fragment
25 kDa
19 to 152
Recombinant
Fc tag C-Terminus
Lyophilized
Involved in T-cell activation, the induction of cell proliferation and cytokine production and promotion of T-cell survival. Enhances the production of IL4 and IL10 in T-cells in conjunction with TCR/CD3 ligation and CD40L costimulation (PubMed:8617933). Isoform 3 enhances CD40L-mediated activation of NF-kappa-B and kinases MAPK8 and PAK2 in T-cells (PubMed:15067037).
CD40LG induces tyrosine phosphorylation of isoform 3.
Blue Ice
-20°C
This product is an active protein and may elicit a biological response in vivo, handle with caution.
This product is manufactured by BioVision, an Abcam company and was previously called 9237 Human CellExp™ CD28, Human Recombinant. 9237-100 is the same size as the 100 μg size of ab286013.
CD28 also known as T-cell-specific surface glycoprotein CD28 or TP44 plays an important role as a co-stimulatory receptor on T cells. This glycoprotein has a molecular mass of about 44 kDa and is located mainly on the cell surface of T cells. CD28 expression also occurs on thymocytes and some B cells. It forms part of the immunoglobulin superfamily featuring in significant antibody interactions. Researchers often use anti-CD28 antibodies for various immunological assays including CD28 ELISA to study its function.
CD28 co-stimulates T cells after antigen presentation. It enhances T cell proliferation survival and cytokine production. CD28 functions alongside the T cell receptor (TCR) complex mediating signals that promote full T cell activation. This interaction amplifies the immune response forming an important axis of immune system communication. CD28 interacts with its ligands B7-1 (CD80) and B7-2 (CD86) found on antigen-presenting cells (APCs) illustrating its role in immune system dynamics.
CD28 is integral to the PI3K/Akt and MAPK/ERK signaling pathways. These pathways conduct signals critical for cellular growth and survival linking CD28 to downstream transcription factors. The interaction with another protein CTLA-4 acts as a regulatory balance for CD28 signaling preventing over-activation of T cells. This balance influences immune homeostasis and tolerance providing a framework for understanding costimulatory and inhibitory signaling.
CD28's role becomes evident in autoimmune diseases and transplant rejection. Abnormal CD28 signaling links to rheumatoid arthritis where inappropriate T cell activation occurs. Similarly CD28 activity contributes to organ transplant rejection by stimulating T cell-mediated responses against transplanted tissues. CTLA-4 through regulatory feedback can modify these effects providing therapeutic target strategies for managing such disorders. Efforts to modulate CD28 activity involve developing therapeutic agents such as anti-CD28 monoclonal antibodies.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
CD28 and CD80-Biotin ELISA binding activity:
Human biotinylated CD80, Fc Tag can bind to immobilized human CD28, Fc Tag at 1 μg/mL, 100 ng/well with a linear range of 0.03 – 0.81 μg/mL.
SDS-PAGE (4-20%): Human CD28, Fc-Tag protein was run on SDS PAGE gel under reducing (R) conditions and stained with Coomassie Blue.
Lane M: Protein Marker
Lane 1: Biotinylated Human CD28 Fc Tag (2 μg)
Lane 2: Human CD28 Fc Tag (2 μg).
The proteins migrate to around 55 kDa due to glycosylation.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com